News

Low incidence of DVT seen in routine MRI of damaged knees


 

FROM JOURNAL OF CLINICAL IMAGING

References

The incidence of deep vein thrombosis (DVT) in knees undergoing routine assessment of damage was found to be low but suggests the need to interrogate the popliteal vein for evidence of thrombosis, according to Dr. Ryan M. Shulman of the joint department of medical imaging of University Health Network and Mount Sinai Hospital, Toronto, and his colleagues.

They documented the appearance and determined the prevalence of findings suspicious for popliteal vein thrombosis on magnetic resonance imaging (MRI) assessment of the knee joint by retrospectively reviewing 2,888 MRI examinations.

© Sebastian Kaulitzki/Thinkstock

MRI images were classified as showing either normal appearing popliteal vein or findings suspicious for popliteal vein thrombosis. They found 2,879 of the MRI studies as having a normal appearing popliteal vein, with 9 showing findings suspicious for popliteal vein thrombosis.

“Although the prevalence of MR findings is low (0.3%), our findings reiterate the need to interrogate the popliteal vein for evidence of thrombosis,” Dr. Shulman and his colleagues concluded.

Find the full study online the Journal of Clinical Imaging 2015 (doi: 10.1016/j.clinimag.2015.09.008).

mlesney@frontlinemedcom.com

Recommended Reading

Three factors boost dabigatran adherence
MDedge Hematology and Oncology
Reserve thrombophilia testing for select subgroups
MDedge Hematology and Oncology
Idarucizumab reverses dabigatran’s anticoagulant effects
MDedge Hematology and Oncology
Study establishes protocol for perioperative dabigatran discontinuation
MDedge Hematology and Oncology
Statins showed no benefit in reducing risk of recurrent VTE
MDedge Hematology and Oncology
High VTE recurrence risk persists for at least 3 years
MDedge Hematology and Oncology
Routine screening sufficient for detecting occult cancer in patients with VTE
MDedge Hematology and Oncology
Anticoagulant therapy not contraindicated in brain metastases
MDedge Hematology and Oncology
Warfarin as effective as LMWH to prevent recurrent VTEs in cancer patients
MDedge Hematology and Oncology
HIT risk rises with obesity
MDedge Hematology and Oncology